...
首页> 外文期刊>European review for medical and pharmacological sciences. >MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA
【24h】

MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA

机译:通过将AKT1作为Cerna将AKT1升高,MAGI1-IT1刺激非小细胞肺癌的增殖

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: This study aims to illustrate the potential role of MAGI1-IT1 in the progression of non-small cell lung cancer (NSCLC) and the underlying mechanism. PATIENTS AND METHODS: The relative level of MAGI1-IT1 in normal lung tissues and NSCLC tissues was determined. Its level in NSCLC patients with different tumor sizes (5 cm or 5 cm), metastatic statues (positive or negative), and tumor staging (stage I+II or stage III+IV) was detected as well. The prognostic potential of MAGI1-IT1 in evaluating the overall survival (OS) and progression-free survival (PFS) of NSCLC patients was assessed by the Kaplan-Meier method. In A549 and PC-9 cells, the regulatory effect of MAGI1-IT1 on the proliferative ability was examined by the cell counting kit-8 (CCK-8), colony formation, and 5-Ethynyl-2’-deoxyuridine (EdU) assay. The target miRNA of MAGI1-IT1 and the target gene binding to miRNA-512-3p were predicted using the Diana database. The interactions among MAGI1-IT1/miRNA-512-3p/AKT1 regulatory loop were tested by the Dual-luciferase reporter gene assay and RNA immunoprecipitation (RIP) assay. At last, the rescue experiments were carried out to uncover the regulatory effect of MAGI1-IT1/AKT1 axis on NSCLC progression. RESULTS: MAGI1-IT1 was upregulated in NSCLC tissues. Its level was higher in NSCLC patients with larger tumor size, positive metastasis, or advanced stage. High level of MAGI1-IT1 predicted worse OS and PFS in NSCLC patients. The knockdown of MAGI1-IT1 remarkably attenuated the proliferative ability in A549 and PC-9 cells. MAGI1-IT1 could target miRNA-512-3p, and AKT1 was the target gene of miR-512-3p. The overexpression of AKT1 stimulated lung cancer cells to proliferate. Of note, the elevated proliferative rate in lung cancer cells overexpressing AKT1 was reversed by the silence of MAGI1-IT1. CONCLUSIONS: MAGI1-IT1 is upregulated in NSCLC tissues and cell lines, and predicts a poor prognosis in NSCLC patients. MAGI1-IT1 stimulates proliferative ability in NSCLC by upregulating the AKT1 level by binding to miRNA-512-3p.
机译:目的:本研究旨在说明MAGI1-IT1在非小细胞肺癌(NSCLC)和潜在机制的进展中的潜在作用。患者和方法:确定了正常肺组织和NSCLC组织中的MAGI1-IT1的相对水平。它在不同肿瘤尺寸(<5cm或5cm),转移静态(阳性或阴性)和肿瘤分期(阶段I + II或阶段III + IV)中的水平也是如此。通过Kaplan-Meier方法评估了在评估NSCLC患者的整体存活(OS)和无进展存活率(PFS)中的MAGI1-IT1的预后潜力。在A549和PC-9细胞中,通过细胞计数试剂盒-8(CCK-8),菌落形成和5-乙炔基-2'-脱氧尿苷(EDU)测定检查MAGI1-IT1对增殖能力的调节作用。使用Diana数据库预测MAGI1-IT1的靶miRNA和与miRNA-512-3P结合的靶基因结合。通过双荧光素酶报告基因测定和RNA免疫沉淀(RIP)测定来测试MAGI1-IT1 / miRNA-512-3P / AKT1调节回路之间的相互作用。最后,进行了救援实验,揭示了在NSCLC进展上的MAGI1-IT1 / AKT1轴的调节作用。结果:MAGI1-IT1在NSCLC组织中上调。 NSCLC患者的水平较高,肿瘤大小较大,阳性转移或晚期阶段。高水平的MAGI1-IT1预测了NSCLC患者的更糟糕的操作系统和PFS。 MAGI1-IT1的敲低显着减弱了A549和PC-9细胞中的增殖能力。 MAGI1-IT1可以靶向miRNA-512-3P,AKT1是miR-512-3p的靶基因。 AKT1的过表达刺激肺癌细胞增殖。值得注意的是,过表达AKT1的肺癌细胞增殖率升高通过MAGI1-IT1的沉默反转。结论:MAGI1-IT1在NSCLC组织和细胞系中上调,并预测NSCLC患者的预后差。通过与miRNA-512-3P结合来上调AKT1水平,MAGI1-IT1刺激NSCLC中的增殖能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号